AI could review data sets to assist clinical scientists ...

Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...

Objective Geriatric patients often face issues related to polypharmacy and adverse drug events. Re-evaluating prescribed medications and considering deprescribing is critical. Medication discrepancies ...

Chemists from St. Petersburg University has developed a new family of luminescent iridium complexes that, for the first time, realize a unique mechanism of photoactivated proton transfer. In the ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

The FDA already authorizes the use of experimental drugs under what’s called “compassionate use,” for people with no other ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

The Supreme Court will hear oral arguments on Monday in United States v. Hemani, the second gun-rights case of the 2025-26 ...

New records from the governor’s office show Indiana paid $100,000 for execution drugs used in October — bringing the total ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

TGIF, and welcome to Health Brief. As is customary on Fridays, I’m wondering what’s on your mind. This Feedback Friday, shoot me a note, and let me know about a topic you’d like to hear more about.